Nasdaq:US$19.10 (-0.15) | HKEX:HK$30.70 (+0.35) | AIM:£3.01 (-0.04)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 1 Apr 2014

AACR 2014: Anti-tumour activity of Epitinib in patient derived esophagus cancer models